Ditte Madsen Andersen

Ditte Madsen Andersen

Auto-generated profile, based on publicly available information

Ditte Madsen Andersen

Department of Cardiology Copenhagen University Hospital ‐ Herlev and Gentofte Copenhagen Denmark

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
DMDaniel Modin
Daniel Modin
RMRasmus Møgelvang
Rasmus Møgelvang
DADitte Madsen Andersen
Ditte Madsen Andersen
TBTor Biering-Sørensen
Tor Biering-Sørensen
Background: Cardiovascular disease remains a leading cause of death. Right ventricular ( RV ) function is a strong predictor of outcome in many cardiovascular diseases, but its significance is often neglected. Little is known about the prognostic value of RV systolic function in the general population. Therefore, we aimed to determine the prognostic value of RV systolic function, evaluated by tricuspid annular plane systolic excursion ( TAPSE ), in predicting cardiovascular death ( CVD ) in the general population. Methods and Results: A total of 1039 participants from the general population without heart failure or atrial fibrillation had an echocardiogram performed and TAPSE measured. The end point was CVD . During a median follow‐up of 12.7 years (interquartile range, 12.0–12.9 years), 69 participants (6.6%) experienced CVD , whereas 162 participants (15.6%) experienced non‐CVD. Decreasing RV systolic function, assessed as TAPSE , was a univariable predictor of CVD (hazard ratio, 1.13; 95% CI , 1.07–1.20; P <0.001, per 1‐mm decrease). TAPSE remained an independent predictor of CVD after adjusting for clinical and echocardiographic parameters (hazard ratio, 1.08; 95% CI , 1.01–1.15; P =0.017, per 1‐mm decrease). Furthermore, in net reclassification analysis, decreasing RV systolic function, assessed as TAPSE, significantly improved risk classification with respect to CVD when added to established cardiovascular risk factors from the Systematic Coronary Risk Evaluation chart or a modified version of the American Heart Association/American College of Cardiology Pooled Cohort Equation. Decreasing RV systolic function, assessed as TAPSE , did not predict non‐CVD, indicating specificity for CVD . Conclusions: RV systolic function, as assessed by TAPSE , is associated with CVD in the general population. In the general population, assessment of RV systolic function may provide novel prognostic information about the risk of CVD .

1 June 2018 in Echo Research & Practice
Verified
Journal Article
Open access
PDF file
DMDaniel Modin
Daniel Modin
DADitte Madsen Andersen
Ditte Madsen Andersen
TBTor Biering-Sørensen
Tor Biering-Sørensen
Heart failure (HF) is a threat to public health. Heterogeneities in aetiology and phenotype complicate the diagnosis and management of HF. This is especially true when considering HF with preserved ejection fraction (HFpEF), which makes up 50% of HF cases. Natriuretic peptides may aid in establishing a working diagnosis in patients suspected of HF, but echocardiography remains the optimal choice for diagnosing HF. Echocardiography provides important prognostic information in both HF with reduced ejection fraction (HFrEF) and HFpEF. Traditionally, emphasis has been put on the left ventricular ejection fraction (LVEF). LVEF is useful for both diagnosis and prognosis in HFrEF. However, echocardiography offers more than this single parameter of systolic function, and for optimal risk assessment in HFrEF, an echocardiogram evaluating systolic, diastolic, left atrial and right ventricular function is beneficial. In this assessment echocardiographic modalities such as global longitudinal strain (GLS) by 2D speckle-tracking may be useful. LVEF offers little value in HFpEF and is neither helpful for diagnosis nor prognosis. Diastolic function quantified by E/e′ and systolic function determined by GLS offer prognostic insight in HFpEF. In HFpEF, other parameters of cardiac performance such as left atrial and right ventricular function evaluated by echocardiography also contribute with prognostic information. Hence, it is important to consider the entire echocardiogram and not focus solely on systolic function. Future research should focus on combining echocardiographic parameters into risk prediction models to adopt a more personalized approach to prognosis instead of identifying yet another echocardiographic biomarker.

1 February 2019 in Journal of Cardiac Failure
Verified
Journal Article
Open access
DMDaniel Modin
Daniel Modin
MSMorten Sengeløv
Morten Sengeløv
PJPeter Godsk Jørgensen
Peter Godsk Jørgensen
FOFlemming Javier Olsen
Flemming Javier Olsen
NBNiels Eske Eske Bruun
Niels Eske Eske Bruun
TBTor Biering-Sørensen
Tor Biering-Sørensen
The prognostic value of LA functional measures in heart failure patients with reduced ejection fraction (HFrEF) is unclear. Therefore, this study investigated the prognostic value of left atrial (LA) functional measures such as the left atrial emptying fraction (LAEF) and the minimal LA volume compared with left atrial volume index (LAVI) in HFrEF patients. A total of 818 HFrEF patients with left ventricular ejection fractions <45% underwent echocardiography. LA volumes were determined by the area-length method from the apical 2-chamber and apical 4-chamber views. LAEF, minimal LA volume indexed to body surface area (MinLAVI), and LAVI were calculated. The end point was all-cause mortality. During a median follow-up of 3.3 years (interquartile range 1.8-4.6 years), 121 patients died (14.8%). Follow-up was 100%. In a final multivariable model adjusting for clinical and echocardiographic parameters, LAEF, but not MinLAVI or LAVI, was an independent predictor of all-cause mortality in HFrEF patients: LAEF: hazard ratio (HR) 1.11 (P = .033) per 5% decrease; MinLAVI: HR 1.03 (P = .57) per 5 mL/m2 increase; LAVI: HR 1.06 (P = .16) per 5 mL/m2 increase. LAEF is an independent predictor of all-cause mortality in HFrEF patients after multivariable adjustment. LAEF provides incremental prognostic value over LAVI in risk stratification of HFrEF patients.

8 September 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
BLBjørn Strøier Larsen
Bjørn Strøier Larsen
FOFlemming Javier Olsen
Flemming Javier Olsen
DADitte Madsen Andersen
Ditte Madsen Andersen
CMChristoffer Læssøe Madsen
Christoffer Læssøe Madsen
RMRasmus Møgelvang
Rasmus Møgelvang
TBTor Biering-Sørensen
Tor Biering-Sørensen
Background: Left atrial (LA) volumes and emptying fraction in the general population may address structural and functional aspects of atrial cardiomyopathy associated with long‐term risk of ischemic stroke in the absence of atrial fibrillation or prior stroke. We investigated the association between LA volumes and function and ischemic stroke. Methods and Results: In a community‐based cohort, we measured LA minimal volume, LA maximal volume, and LA emptying fraction by transthoracic echocardiography. The primary end point was ischemic stroke. Participants with known atrial fibrillation or prior ischemic stroke were excluded, which resulted in 1866 participants. The mean age was 58±16 years, and 57% were women. During a median follow‐up of 16.5 years (interquartile range: 11.4–16.8 years), 176 (9.4%) ischemic strokes occurred. In multivariable cause‐specific regression models and competing risk models with death as a competing risk, LA emptying fraction was associated with ischemic stroke (hazard ratio [HR], 1.14 per 10% decrease [95% CI, 1.02–1.28]) and (subdistribution HR, 1.14 [95% CI, 1.01–1.29]). This association remained when adjusting for participants who developed atrial fibrillation during follow‐up (HR, 1.12 per 10% decrease [95% CI, 1.00–1.26]). Indexed LA volumes were not associated with ischemic stroke in the same models. LA emptying fraction and indexed LA volumes were not associated with all‐cause mortality. Conclusions: Lower LA emptying fraction measured by transthoracic echocardiography was associated with future ischemic stroke independently of incident atrial fibrillation. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02993172.

5 January 2022 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
DADitte Madsen Andersen
Ditte Madsen Andersen
MSMorten Sengeløv
Morten Sengeløv
FOFlemming Javier Olsen
Flemming Javier Olsen
JMJacob Louis Marott Msc
Jacob Louis Marott Msc
GJGorm Boje Jensen
Gorm Boje Jensen
TBTor Biering‐Sørensen
Tor Biering‐Sørensen